Conservative treatment of neurogenic bladder dysfunction;Konservative therapie der neurogenen blasendysfunktion

Urologe - Ausgabe A

Volumn 38, Issue 1, 1999, Pages 24-29

  Madersbacher, H ^a  

^a Landeskrankenhaus University Hospital   (Austria)

Author keywords

Adult; Child; Clean intermittent catherization; Conservative treatment; Neurogenic bladder dysfunction

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; BLADDER DYSFUNCTION; BLADDER PRESSURE; CATHETERIZATION; CHILD; CONSERVATIVE TREATMENT; DETRUSOR MUSCLE; ELECTROSTIMULATION THERAPY; HUMAN; KIDNEY FUNCTION; MUSCLE CONTRACTION; NEUROGENIC BLADDER; REVIEW; TREATMENT PLANNING; VALSALVA MANEUVER;

ADULT; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; URETHRA; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; URINARY CATHETERIZATION; URODYNAMICS;

EID: 0032972296     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050240     Document Type: Review

References (37)

1. Amarenco G, Marquis P, McCarthy C, Richard F (1998) Qualité de vie des femmes souffrant d'impérisite mictionelle avec ou sans fuites - etude prospective aprés traitement par oxybutynine (1701 cas). Presse Med 27:5-10
2. Anderson RU (1980) Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol 123: 364-366
3. Andersson K-E (1988) Current concepts in treatment of disorders of micturition. Drugs 35: 477-494
4. Cheng EY, Richards I, Kaplan WE (1996) Use of bladder stimulation in high risk patients. J Urol 156: 749-752
5. Collas D, Malone-Lee JG (1997) The pharmacokinetic properties of rectal oxybutynin -a possible alternative to intravesical administration. J Neurourol Urodyn 16: 346-347
6. de Ridder D, Chandiramani V, Dasgupta P, Poppel HV, Baert L (1997) Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long term follow-up. J Urol 158: 2087-2092
7. Ebner A, Jian CH, Lindström S (1992) Intravesical electrical stimulation - an experimental analysis of the mechanism of action. J Urol 148: 920-924
8. Estornell-Moragues F, Nieto-Carcia A, Mazon-Ramos A, Reig-Ruiz C, Martinez-Verduch M, Dominguez-Hinarejos C, Garcia-Ibarra F (1997) Latex allergy in children with myelomeningocele - incidence and associated factors. Actas Urol Esp 21: 227-235
9. Fowler CJ, Jewkes D, McDonald WI, Lynn B, deGroat WC (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339: 1239
10. Ghoniem GM, Shoukry MS, Hassouna ME (1998) Detrusor properties in myelomeningocele patients: in vitro study. J Urol 159: 2193-2196
11. Guttmann L (1976) Spinal shock. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 26, North Holland, Amsterdam, pp 243-262
12. Herberg KW, Fusgen I (1997) Einfluss von Trospiumchlorid, Oxybutynin-HCL und Propiverin-HCL auf sicherheitsrelevante Leistungen. Effect of trospium chloride, oxybutynin-HCL and propiverin-HCL on traffic related performance with respect to safety. Geriatrie Forschung 7: 77-83
13. Kaplinsky R, Greenfield S, Wan J, Fera M (1996) Expanded follow-up of intravesical oxybutynin chloride use in children with neurogenic bladder. J Urol 156: 753-756
14. Katona F (1975) Stages of vegetative afferentation in reorganization of bladder control during electrotherapy. Urol Int 30: 192-203
15. Lapides J, Diokno AC, Gould FR, Lowe BS (1976) Further observations on self catheterization. J Urol 116: 169-172
16. Lazzeri M, Beneforti P, Turini D (1997) Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. J Urol 158: 2093-2096
17. Lloyd LK, Kuhlemeier KV, Stover SL (1986) Initial bladder management in spinal cord injury: does it make a difference? J Urol 135: 523-526
18. Madersbacher H (1984) Blasen(re)habilitation bei Kindern mit neurogener Harnentleerungsstörung mittels Biofeedback unter Verwendung der intravesikalen Elektrotherapie. Akt Urol 15: 248-253
19. Madersbacher H, Hetzel H, Gottinger F, Ebner A (1987) Rehabilitation of micturition in adults with incomplete spinal cord lesions by intravesical electrotherapy. Neurourol Urodyn 6: 230-232
20. Madersbacher H, Stöhrer M, Richter T, Burgdörfer H, Hachen HJ, Mürtz G (1995) Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyperreflexia. Br J Urol 75: 452-456
21. Madersbacher H (1976) Die neurogen gestörte Harnröhre - Urethrogramm und pathophysiologische Aspekte. Urologe [A] 15: 1-12
22. Madersbacher H, Kiss G, Mair D (1995) Transcutaneous electrical stimulation of the pudendal nerve for treatment of detrusor overactivity. J Neurourol Urodyn 14: 501-502
23. Hughes KM, Lang JC, Lazare R, Gordon D, Stanton SL, Malone-Lee J, Geraint M (1992) Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers. XENOBIOTICA 22: 859-869
24. Nilvebrant L, Andersson K-E, Gillberg P-G, Stahl M, Sparf B (1997) Tolterodine - a new bladder selective antimuscarinic agent. Eur J Pharmacol 327: 195-207
25. Palmer LS, Richards I, Kaplan WE (1997) Age related bladder capacity and bladder capacity growth in children with myelomeningocele. J Urol 158: 1261-1264
26. Pearman JW (1971) Prevention of urinary tract infection following spinal cord injury. Paraplegia 9: 95-104
27. Pietzko A, Dimpfel W, Schwantes U, Topfmeier P (1994) Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol 47: 337-343
28. Rutkowski SB, Middleton JW, Truman G, Hagen DL, Ryan JP (1995) The influence of bladder management on fertility in spinal cord injured males. Paraplegia 33: 263-266
29. Saxdorph MH (1878) Stricture urethrae -Fistula perinee - Retentio urinae. Clinsk Chirurgi, Copenhagen: Gyldendalske Fortag, pp 265-280
30. Schellenberg R (1988) Objektive Erfassung von zentralen Nebenwirkungen, peripher wirksamer Pharmaka anhand des EEG. Referateband 1998, 10.Deutscher Kongreß der GIH in Kassel
31. Schönberger B (1988) Pharmakotherapie bei komb. Urge-Stress-Inkontinenz. Referateband 1998, 10. Deutscher Kongreß der GIH in Kassel
32. Stöhrer M, Madersbacher H, Richter R, Wehnert J (1998) Double-blind, placebo-controlled clinical study of propiverine in patients suffering from detrusor hyperreflexia. J Spinal Cord (in press)
33. Stover SL, Lloyd LK, Waites KB, Jacksor AB (1991) Neurogenic urinary tract infection. Neurol Clin 9: 741-755
34. van Poppel H, Ketelaer P, van DeWeerd A (1985) Interferential therapy for detrusor hyperreflexia in multiple sclerosis. Urology 26: 607-612
35. Wehnert J, Sage S (1987) Die transurethrale Elektrostimulation zur Therapie postoperativer Blasenentleerungsstörungen nach erweiterter Hysterektomie. Zentralbl Gynäkol 109: 1104-1110
36. Wiart L, Joseph PA, Petit H, Dosque JP, de Seze M, Brochet B, Deminiere C, Ferriere JM, Mazaux JM, N'Guyen P, Barat M (1998) The effects of capsaicin on the neurogenic hyperi eflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Spinal Cord 36: 95-99
37. Yokota W, Yamaguchi O, Shishido K, Shiraiwa Y (1994) Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabit. J Neurourol Urodyn 13: 466-467